-
Recalled prescription drug Evrysdi -
Recalled prescription drug with press-in bottle adapter
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
About 14,000
Genentech at 800-334-0290 from 8 a.m. to 8 p.m. ET Monday through Friday or online at www.Evrysdi.com and click on the “leaking bottles safety information” banner on the homepage for more information.
Recall Details
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have “Evrysdi (risdiplam) for oral solution,” the dosage and “NDC 20242-175-07” on the front of the bottle labels.
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Genentech has received 26 reports of leaking bottles. No injuries have been reported.
Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.
If you are experiencing issues with a recall remedy or believe a company is being non-responsive to your remedy request, please use this form and explain the situation to CPSC.
Related Recalls
The highchairs pose a fall hazard and risk of serious injury or death to babies because the legs of the chair can detach from the frame if the screws connecting the legs are not properly tightened during assembly.
The recalled high chairs pose a deadly entrapment hazard because the opening between the seat and tray is large enough that a child can become entrapped in it. In addition, the child restraint system can fail, posing a fall hazard. These are violations of the federal standards for high chairs.
The toy sets contain small balls that violate regulations for toys intended for children under three years of age because they are a choking hazard and can cause serious injury or death.
The recalled portable hook-on chair poses a deadly fall hazard because the crotch restraint can be removed without the use of a tool and infants can fall through an opening, which is a violation of the federal standard for portable hook-on chairs.
The recalled portable bassinets violate the federal safety standard for Infant Sleep Products because the sides are too low to contain the infant and the portable bassinets do not have a stand, posing a fall hazard. These violations create an unsafe sleeping environment for infants.
The swings pose a deadly suffocation risk because they were marketed for infant sleep and they have an incline angle greater than 10 degrees, in violation of the CPSC’s Infant Sleep Products Standard and Safe Sleep for Babies Act. The swings also fail to meet mandatory warning requirements under the swing standard. In addition, the remote control for the swing contains a lithium coin battery and the products are missing the required warnings and instructions for consumer products containing button cell and coin batteries under Reese’s Law. When button cell or coin batteries are swallowed, the ingested batteries can cause serious injuries, internal chemical burns and death.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. Since the CPSC was established more than 50 years ago, it has worked to ensure the safety of consumer products, which has contributed to a decline in injuries associated with these products.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
For lifesaving information:
- Visit CPSC.gov.
- Sign up to receive our email alerts.
- Follow us on Facebook, Instagram, X, BlueSky, Threads, LinkedIn and Truth Social.
- Report a dangerous product or product-related injury on www.SaferProducts.gov.
- Call CPSC’s Hotline at 800-638-2772 (TTY 800-638-8270).
- Contact a media specialist.
